Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Definition of chronic GvHD no yes Skin score 1 Skin score 2 Skin score 3 Mouth score 1 Mouth score 2 Mouth score 3 Eyes score 1 Eyes score 2 Eyes score 3 GI tract score 1 GI tract score 2 GI tract score 3 Liver score 1 Liver score 2 Liver score 3 Lungs score 1 Lungs score 2 Lungs score 3 no manifestation / no symptoms presence of at least 1 diagnostic clinical sign of cGvHD or presence of at least 1 distinctive manifestation confirmed by pertinent biopsy or other relevant tests <18% BSA with disease signs but NO sclerotic features 19-50% BSA OR involvement with superficial sclerotic features “not hide-bound” (able to pinch) >50% BSA OR deep sclerotic features “hidebound“ (unable to pinch) OR impaired mobility, ulceration or severe puritus Mild symptoms with disease signsbut not limiting oral intake significantly Moderate symptoms with disease signs with partial limitation of oral intake Severe symptoms with disease signs on examination with major limitation of oral intake Mild dry eye symptoms not affecting ADL (requiring eyedrops ≤ 3 x per day) OR asymptomatic signs og keratoconjunctivitis sicca Moderate dry eye, symptoms partially affecting ADL (requiring eyedrops >3 x per day or punctual plugs), without vision impairment Severe dry eye symptoms significantly affecting ADL (special eyeware to relieve pain) OR unable to work because of ocular symptoms OR loss of vision caused by keratoconjunctivitis sicca Symptoms such as dysphagia, anorexia, nausea, vomiting, abdominal pain or diarrhea without significant weight loss (< 5%) Symptoms associated with mild to moderate weight loss (5- 15%) Symptoms associated with significant weightloss >15%, requires nutritional supplement for most calorie needs OR esophageal dilation Elevated Bilirubin, AP, AST or ALT <2 x ULN Bilirubin >3 mg/dl or Bilirubin, enzymes 2-5 x ULN Bilirubin or enzymes > 5 x ULN Mild symptoms (shortness of breath after climbing one flight of steps) FEV1 60-79% OR LFS 3-5 Moderate symptoms (shortness of breath after walking on fiat ground) FEV1 40-59% OR LFS 6-9 Severe symptoms (shortness of breath at rest; requiring O2) FEV1 ≤ 39% OR LFS 10-12 Mild tightness of arms or legs, normal or mild de-creased range of motion (ROM) AND not Joints and Fascia score 1 affecting ADL Tightness of arms or legs OR joint contractures, erythema thought due to fasciitis, moderate Joints and Fascia score 2 decrease ROM AND mild to moderate limitation of ADL Contractures WITH significant decrease of ROM AND significant limitation of ADL (unable to Joints and Fascia score 3 tie shoes, button shirts, dress self etc.) Genital Tract score 1 Symptomatic with mild signs on exam AND no effect on coitus and minimal discomfort with gynecologic exam Genital Tract score 2 Symptomatic with moderate signs on exam AND with mild dyspareunia or discomfort with gynecologic exam Genital Tract score 3 Symptomatic WITH advanced signs (stricture, labial agglutination or severe ulceration) AND severe pain with coitus or inability to insert vaginal speculum Performance score 1 KPS, ECOG, LPS Symptomatic fully ambulatory, restricted only in physically strenuous, (ECOG 1 KPS or LPS 80- 90%) Performance score 2 KPS, ECOG, LPS Symptomatic ambulatory, capable of self-care , >50% of waking hours out of bed (ECOG 2 KPS or LPS 60-70%) Performance score 3 KPS, ECOG, LPS Symptomatic limited self-care>50% of waking hours in bed (ECOG 3-4, KPS or LPS < 60%) Overall grade of chronic GvHD Mild chronic GvHD Moderate chronic GvHD Severe chronic GvHD involvement of 1 or 2 organs (exept lung) with a maximum score 1 in all affected organs or sites at least 1 organ with a maximum score 2 or 3 or more organs with a maximum score 1 or a lung score 1 score of 3 in any organ or site or a lung score of ≥ 2